Burlingame, California
United States
39
2023-10-05
The entities that hold a legal rights for patent applications filed by inventor Lazerwith Scott E.:
Scott E. Lazerwith from Burlingame, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Capsid inhibitors for the treatment of HIV
#2 | 2023-08-31Thienopyrrole compounds
#3 | 2023-08-31Substituted pyrrolizine compounds and uses thereof
#4 | 2023-05-11SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF
#5 | 2023-03-23POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#6 | 2023-02-09Capsid inhibitors for the treatment of HIV
#7 | 2022-12-08Thienopyrrole compounds
#8 | 2022-10-27MCL-1 inhibitors
#9 | 2022-05-12Phospholipid compounds and uses thereof
#10 | 2022-03-17Phospholipid compounds and uses thereof
#11 | 2021-08-19SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF
#12 | 2021-05-20Substituted pyrrolizine compounds and uses thereof
#13 | 2021-02-25Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections
#14 | 2021-01-21POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#15 | 2021-01-14THERAPEUTIC COMPOUNDS
#16 | 2020-12-17Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
#17 | 2020-10-22MCL-1 inhibitors
#18 | 2020-07-16Synthesis of polycyclic-carbamoylpyridone compounds
#19 | 2020-02-27Substituted pyrrolizine compounds and uses thereof
#20 | 2019-11-21MCL-1 inhibitors
#21 | 2019-09-26Substituted pyrrolizine compounds and uses thereof
#22 | 2019-08-08Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#23 | 2019-03-28Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections
#24 | 2019-02-14POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#25 | 2019-01-17CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
#26 | 2018-09-27THERAPEUTIC COMPOUNDS
#27 | 2018-08-02POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#28 | 2018-06-14Substituted pyrrolizine compounds and uses thereof
#29 | 2018-06-07POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#30 | 2018-04-26Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#31 | 2018-01-25Synthesis of polycyclic-carbamoylpyridone compounds
#32 | 2017-11-23Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide
#33 | 2017-09-14Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections
#34 | 2017-05-04Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#35 | 2017-03-02Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections
#36 | 2016-12-22Syk inhibitors
#37 | 2016-06-23Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections
#38 | 2016-04-21Therapeutic compounds
#39 | 2015-12-24Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
1862634 ⎘